Hypertensie High blood pressure hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Signed written informed consent. - Age >18 years and 45. - A patient who is mentally competent with the ability to understand and comply with the requirements of the study. - The patient agrees to attend all follow-up evaluations and is willing to complete required exams and tests.
Exclusion criteria
Exclusion criteria: - Previous participation in another study with any investigational drug or device within the past 30 days. - Relevant renal artery disease (% diameter stenosis>30%, aneurysm or fibromuscular dysplasia). - Known secondary causes of hypertension. - The patient has a life expectancy * 12 months. - The patient has undergone prior renal denervation, renal stenting, and/or abdominal aortic stent grafts. - The patient has chronic oxygen use other than nocturnal support for sleep apnea. - The patient has type I diabetes mellitus. - The patient has had a previous organ transplant or is awaiting a renal transplant. - Active implantable medical device (e.g. ICD or CRT-D; neuromodulator/spinal stimulator; baroreflex stimulator). - The patient has triple ipsilateral artery ostia. - Moderate to severe valvular heart disease. - The patient has other concomitant conditions that may adversely affect the patient or the study outcome. - Female who is pregnant, nursing or planning to become pregnant. - Documented contraindication or allergy to contrast medium not amenable to treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of serious adverse events (system and/or procedure related events). | — |
Secondary
| Measure | Time frame |
|---|---|
| Arterial blood pressure changes to renal nerve stimulation. | — |
Countries
Greece